The purpose of this multicenter observational clinical study was to evaluate the performance of a near-infrared (NIR)-based, non-invasive, portable device to screen for traumatic intracranial hematomas. Five trauma centers collected data using the portable NIR device at the time a computed tomography (CT) scan was performed to evaluate a suspected traumatic brain injury (TBI). The CT scans were read by an independent neuroradiologist who was blinded to the NIR measurements. Of 431 patients enrolled, 365 patients were included in the per-protocol population analyzed. Of the 365 patients, 96 were determined by CT scan to have intracranial hemorrhages of various sizes, depths, and anatomical locations. The NIR device demonstrated sensitivity of 88% (95% confidence interval [CI] 74.9,95.0%), and specificity of 90.7% (95% CI 86.4,93.7%), in detecting the 50 intracranial hematomas that were large enough to be clinically important (larger than 3.5 mL in volume), and that were less than 2.5 cm from the surface of the brain. For all 96 cases with intracranial hemorrhage, regardless of size and type of hemorrhage, the sensitivity was 68.7% (CI 58.3,77.6%), and specificity was 90.7% (CI 86.4,93.7%). These results confirm the results of previous studies that indicate that a NIR-based portable device can reliably screen for intracranial hematomas that are superficial and of a size likely to be of clinical importance. The NIR device cannot replace CT scanning in the diagnosis of TBI, but the device might be useful to supplement clinical information used to triage TBI patients, and in situations in which CT scanning is not readily available.
Introduction
O ne hallmark pathological process in traumatic brain injury (TBI) is intracranial hemorrhage, which occurs in 45% of severe head trauma cases . There are four major types of traumatic intracranial hemorrhage: subdural, epidural, and intracerebral hematomas, and subarachnoid hemorrhage. Each of these lesions has characteristic clinical and CT scan findings, and can be present on admission to the hospital, or can occur in a delayed fashion (Silver et al., 2005) .
Early diagnosis and surgical evacuation of intracranial hematomas are fundamental management principles for traumatic hematomas (Bullock et al., 2006) . A practical adjunct to this goal of early identification of intracranial hematomas in the field and emergency center may be the use of portable near-infrared (NIR) technology.
In a pilot study (305 patients) conducted with a prototype NIR unit, sensitivity for extracerebral (epidural and subdural) hematomas was 100%, and sensitivity for intracerebral hematomas was 98%, compared to CT scan readings . There were no falsepositives. In 93% of late-onset lesions the NIR system detected onset more rapidly than conventional monitoring methods (ICP monitoring and repeated neurological examinations). The type of hematoma could not be determined with certainty in the pilot study; however, it was possible to detect the presence of any type of traumatic intracranial hematoma.
Other groups have reported similar experiences with the use of NIR technology to identify intracranial hematomas. Kahraman and associates (2006) studied the use of an NIR device in patients with subdural and epidural hematomas, and found an overall sensitivity of 0.87 compared to CT scanning. All patients with acute intracranial hematomas were identified. The four patients in this study in whom a subdural hematoma was not detected with the NIR device had chronic subdural hematomas for which the absorption characteristics of the blood may have been different. Francis and colleagues (2005) studied 71 patients undergoing CT scanning for a suspected brain lesion. All of the patients with a difference in optical density detected by the NIR technique had a unilateral lesion on CT scan. In two trauma centers, where 110 patients underwent evaluation with a portable NIR device prior to CT scanning, the NIR assessment had a sensitivity of 90.5% and specificity of 95.5% for extracerebral hematomas (Kessel et al., 2007) .
Early identification of intracranial hematomas in TBI patients allows early surgical evacuation, which can be an important determinant of outcome. In one study, Seelig and associates (1985) showed that a delay of more than 4 h between injury and the evacuation of a traumatic subdural hematoma increased mortality and worsened outcome in survivors.
An NIR-based, hand-held medical screening tool (Infrascanner by InfraScan, Inc.) has recently been developed to screen for a brain hematoma at the site of injury. In laboratory tests with phantom models of intracranial hematomas, the smallest volume of blood that could be detected with the device was 3.5 mL, and the hematoma had to be within 2.5 cm of the brain surface to be detected.
The purpose of this clinical study was to evaluate the performance of this NIR-based portable device in the detection of intracranial hemorrhage due to trauma. The primary endpoint of the study was a description of the test characteristics (sensitivity, specificity, and positive and negative predictive values [PPV and NPV] ) of the portable NIR-based device in the identification of any size hematoma compared to CT as the gold standard. A secondary end-point was the description of the test characteristics of the portable NIR-based device in identification of hematomas within its detection limits (volume >3.5 mL and depth <2.5 cm), compared to CT scan results as the gold standard.
Methods

Theoretical basis for detection of hematomas with NIR technology
Due to the unique light-absorbing properties of hemoglobin, hemoglobin molecules within tissue have the highest absorption rate in the NIR range (700-900 nm; Cope, 1991; Rolfe, 2000; . Therefore, any change in hemoglobin concentration will be reflected in the attenuation of measured light that has interacted with the tissue of interest. The basic method for hematoma detection using NIR technology is based on differential light absorption of the left versus the right side of the brain. Under normal circumstances the brain's absorption is symmetrical. Where additional underlying extravascular blood is present, there is a greater local concentration of hemoglobin, and consequently the absorbance of the light is greater, while the reflected component is commensurately less. This differential is detectable via sources and detectors placed over symmetrical locations on the two sides of the skull. Furthermore, NIR technology is now available in small, battery-operated, and therefore easily portable designs.
Study design
The study was a multi-center observational study to test the performance of the new portable NIR device to screen for intracranial hemorrhage, by comparing the findings of the NIR exam to those of the admission CT scan.
Setting
The study was conducted in the emergency center of five trauma centers, four Level 1 trauma centers that were in the United States, and a fifth center in India.
Selection of participants
Patients of any age were eligible for the study if they were undergoing a CT scan within 12 h of a blunt or penetrating head injury at any of the five trauma centers participating in the study, between July 2006 and October 2008. Trained operators were available during hours expected to be highvolume for trauma, approximately 20 h per week. All eligible patients were enrolled during those time periods.
The criteria for obtaining a CT scan were based on the standard of care. The non-contrast CT was performed according to standard methods at the local institution. Exclusion criteria included the presence of large scalp lacerations, avulsions, or hematomas involving the NIR examination sites.
This study was performed with a waiver of informed consent approved by the local institutional review boards of the participating centers, based on the minimal risk of the study procedure. Patients who could not give informed consent for themselves were studied, because this is the population of head trauma patients that have a significant risk of having intracranial hematomas, and would most benefit from the screening device. The clinical need to emergently diagnose and evacuate intracranial hematomas precluded obtaining surrogate consent. The study procedure had minimal risk because the NIR examination was non-invasive, quick, and did not interfere with routine patient care.
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Methods of measurement
The NIR device consists of two components: a sensor and a personal digital assistant (PDA). The sensor includes an 808-nm diode laser and a silicon detector. The sensor delivers NIR light to the tissue under the sensor via fiberoptics, and receives it after it has interacted with the tissue. The detector signal is then digitized and transmitted via a Bluetooth wireless link to the PDA. The PDA receives the data from the sensor, processes it further, and displays the results on its screen. The fiberoptics are designed so that they can be maneuvered between hairs to minimize the interference from thick, dark hair without shaving the hair.
Within 40 min before the CT scan was performed for clinical indications, an operator independently performed a standardized examination with the portable NIR device. Measurements were made at four pre-selected pairs of locations on the head: the frontal, temporal, parietal, and occipital regions (with a variance of AE 1 cm). At each location, the actual measurement by the portable NIR device takes up to 10 sec. The entire head scan takes less than 2 min. If the time gap between the NIR measurements and CT examinations was more than 40 min, which happened if the CT scan was delayed more than expected, then a second examination with the portable NIR device was performed within 40 min after the CT scan, with the operator still blinded to the results of the CT scan. The second exam, performed within 40 min of the CT scan, was used in the analysis.
Operators at each study site were identified and trained both about how to use the NIR equipment, and about how to place the device in the appropriate locations for the standardized examination. This training involved a half-day site visit to the center, during which an instructor provided a demonstration of the NIR device, followed by supervision of practice examinations on normal individuals. Only trained operators contributed patients to the study.
In order to interpret the NIR examination, the absorption of light, which is related to hemoglobin content within the four scanned areas on the left side of the head, was compared with the absorption of light obtained on the corresponding locations on the right side, obtaining a difference in optical density (DOD) for each of the four pairs of locations on the head. The optical density measurement is a logarithm of the measured light intensity: OD ¼ log 10 I. For each examination the DOD for each of the four brain regions was recorded, and the DOD max , defined as the greatest absolute value for DOD among the various regions examined, was recorded. The presence or absence of a hematoma was determined by comparing the DOD max measurement to a pre-defined threshold of 0.2. This threshold was determined based on a pilot study in TBI patients , and a pilot study with healthy volunteers. Variability due to accidental hair compression is one of the reasons that the detection threshold of the Infrascanner was set to 0.2 (to maximize specificity). The other factor in determining the detection threshold was the distribution of hematoma signals (to maximize sensitivity). In each head region where the DOD was more than the threshold of 0.2, the measurement was repeated to confirm the finding, and to reduce the chances of a false reading due to hair trapped under the lightguides.
A neuroradiologist from an independent clinical site separate from the five hospitals involved in patient scanning evaluated all of the CT scans and entered the results in a database. The matching NIR device recordings were entered in the same database by the clinicians at the five clinical sites. In order to eliminate any possible bias, the neuroradiologist was blinded to the NIR measurements, and the clinicians who entered the NIR device measurements were blinded to the CT scan readings in the database. An independent statistician compared the performance of the portable NIR-based device in hematoma detection using CT scan results as the gold standard.
The primary end-point of the study was a description of the test characteristics (sensitivity, specificity, and positive and negative predictive values) of the portable NIR-based device in the identification of any size hematoma compared to CT as the gold standard. A secondary end-point was the description of the test characteristics of the portable NIR-based device in identification of hematomas within its detection limits (volume >3.5 mL and depth <2.5 cm), compared to CT scan results as the gold standard. Other exploratory analyses were performed to examine factors such as hematoma type and size, and study site.
Primary data analysis
The analyses of the performance of the portable NIR-based device were conducted using a ''per-protocol'' population. Patients were excluded from the analysis if they had large scalp lacerations or hematomas or blood on the scalp over the scan area. Patients were also excluded from the analysis when the NIR device malfunctioned (e.g., because it was not charged), when symmetrical bilateral measurements were not made, or when the NIR examination was not performed within 40 min of the CT scan.
Results
Characteristics of the study subjects
All age groups were represented in this study, with a range in age from 1 to 89 years (Table 1 ). Demographics were similar for patients among the different clinical sites, and the 365 perprotocol cases were representative of the whole group. Out of 431 patients, males were evaluated for suspected TBI approximately three times more often than females. Characteristics that might affect performance of an optical method, such as race, skin and hair color, and hair thickness, were represented in significant numbers in the patient population. The mechanism of brain injury, from most frequent to least frequent, were vehicular accidents (including motorized and non-motorized vehicle accidents), falls, assaults, gunshot wounds, and others (such as sports-related accidents and birth trauma).
The per-protocol population, as defined in the methods section, included 365 patients. The protocol violations that excluded the other 66 patients from the analysis were time between NIR exam and CT scan >40 min (n ¼ 39), blood or lacerations on the scalp over the scan area (n ¼ 11), asymmetric placement of the NIR device (n ¼ 13), measurement by untrained operators (n ¼ 2), and use of an uncharged NIR system (n ¼ 1). In the per-protocol group, there were 31 (32.2%) subdural hematomas, 23 (24%) epidural hematomas, 29 (30.2) intracerebral hematomas or contusions, and 13 (13.5%) patients with subarachnoid hemorrhage, for a total of 96 (26.3%) patients with intracranial hemorrhage. The remaining 269 patients did not have intracranial hemorrhage.
Main results
The distribution of DOD values for all 365 per-protocol patients is illustrated in Figure 1 , separated by whether or not intracranial hemorrhage of any type and size was identified on the initial CT scan. The DOD for the 269 patients in whom no intracranial hemorrhage was identified on the initial CT scan ranged from 0 to 1.05, but 90.7% of the cases were <0.20, which was pre-defined as the threshold for identification of intracranial hemorrhage. The variability in these nonhemorrhage cases was greater than in the pilot trial. The main reason for the variability is probably accidental hair compression, which happens even if the user tries to wiggle the optical fibers through the hair.
Of the 96 cases in whom intracranial hemorrhage of any size and type was identified on CT scan, 66 cases had a DOD greater than the pre-defined threshold of 0.2, for an overall FIG. 1. Distribution of difference in optical density (DOD) for patients with intracranial hemorrhage present (n ¼ 96), and intracranial hemorrhage absent (n ¼ 269).
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sensitivity of 68.7%. Table 2 shows the full performance data for all of the per-protocol cases. Specificity was 90.7%, NPV was 89.0%, and PPV was 72.5%. The type and size of the intracranial hemorrhage was the major factor that affected the performance of the NIR device. Figure 2 shows the distribution of DOD values by type and size of hemorrhage. Most of the 30 DOD values <0.2 in patients with intracranial hemorrhage (the false-negatives) occurred in cases in whom the characteristics of the hematoma were outside the detection limits of the NIR device (n ¼ 20), or were subarachnoid hemorrhage (n ¼ 4).
The DOD values in the subarachnoid hemorrhage cases, in whom the volume of blood could not be estimated, was quite variable, and ranged from 0.03 to 0.86. The distribution of DOD values for epidural, subdural, and intracerebral hematomas and contusions within the NIR device detection limits (>3.5 mL and <2.5 cm from the brain surface) is shown in black. Of the 50 cases with a hematoma within the detection limits, 44 had a DOD value >0.2, for a sensitivity of 88%. The full performance data for this subgroup of cases is also shown in Table 2 . Specificity was 90.7%, NPV was 97.6%, and PPV was 63.7%.
The median volume of blood in the individual hematoma cases was 8.6 mL, and varied tremendously, from a low value of 0.1 mL to a high value of 133 mL. The distribution of hematoma volumes is shown in Figure 3 . The effect of hematoma volume on the sensitivity of the NIR measurements for the epidural, subdural, and intracerebral hematoma and contusion cases is shown in Table 3 . When only very-large-volume hematoma cases were included in the analysis (>70 mL) the sensitivity was 100%, and all of the hematomas were detected. When hematoma volume was >25 mL, which might in some circumstances indicate a hematoma that would require surgical evacuation, the sensitivity was 93.3%. When smaller hematoma cases were included in the analysis, the sensitivity dropped significantly. There was not a significant difference in performance of this portable NIR-based device at the different locations of the medical centers.
As shown in Figure 4 , the information provided by the NIR exam supplemented the clinical information provided by the neurological examination. The baseline prevalence of intracranial hematoma in the per-protocol population was 27%. In patients with an abnormal neurological examination (Glasgow Coma Scale [GCS] score <15), the PPV was 47%. In   FIG. 2 . The distribution of difference in optical difference (DOD) values for all hemorrhage categories (E, epidural hematoma; S, subdural hematoma; I, intracerebral hematoma; C, contusion; SAH, subarachnoid hemorrhage). patients with a DOD >0.2 regardless of the neurological examination, the PPV was 63%. However, in patients with an abnormal neurological examination and with a DOD >0.2, the PPV was 80%.
Discussion
This study confirms the findings of previous investigations demonstrating that NIR technology can be used to screen for the presence of intracranial blood from a simple examination of the difference in optical density between the area involved in the hemorrhage and the uninvolved site on the opposite side of the head . Unlike previous studies, this protocol assessed the performance of the NIR device to identify all types of intracranial hemorrhage. While the sensitivities for identifying extracerebral (subdural and epidural) hematomas in the studies by Kahraman and colleagues (2006) and Kessel and associates (2007) were 87% and 90.5%, respectively, the sensitivity in the present study for all types of intracranial hemorrhage was only 68%. The size and type of intracranial hemorrhage present seemed to be the major factor affecting the performance of the NIR-based device.
The portable NIR-based device demonstrated high sensitivity (88%) and specificity (90.7%) in detecting traumatic intracranial hematomas >3.5 mL in volume and <2.5 cm from the surface of the brain. With hematomas >25 mL in volume, a size that would be likely to cause mass effect and to require surgical evacuation (Bullock et al., 2006) , the sensitivity was 93.3%. With very small hematomas (<3.5 mL), or hematomas that are more distant (>2.5 cm) from the brain surface, the sensitivity was lower. The clinical usefulness of this technology to identify hematomas therefore will depend on the type of brain disorder being examined. For TBI, for which the majority of the hematomas are subdural or epidural, and in which many intraparenchymal hematomas involve the surface of the brain, the sensitivity should be good.
FIG. 3.
The distribution of the volumes of the 83 epidural, subdural, and intracerebral hematomas, and contusion cases. These hematomas were >3.5 mL volume and <2.5 cm from brain surface. 95% CI, exact 95% confidence interval.
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The PPV of the NIR examination was 63.7% and the NPV was 97.6%. For these predictive value calculations, it should be noted that for rare disorders, the major determinant of the predictive value of the test is the prevalence of the disorder in the population tested (Altman and Bland, 1994) . Regardless of the test's sensitivity and specificity, if the population is at low risk of having the disorder, positive results are more likely to be false-positives, decreasing the PPV. Likewise, if prevalence is low, negative results are likely to be true-negatives, increasing the NPV. Since the prevalence of intracranial hematomas was 15.6% in the population studied, the predictive values have only limited usefulness.
Several limitations of the study design should be acknowledged. One confounding factor for NIR technology with TBI patients is injury to the scalp. Blood contained within a scalp hematoma can alter the DOD and cause a false-positive result with this technology. The presence of a scalp laceration or hematoma was an exclusion criterion for this study, and was also one of the common reasons for excluding cases from the per-protocol analysis. In clinical practice, however, patients with scalp injuries need to be evaluated for head injury, and would be more likely to have a false-positive result with this technology. This may be a limitation in generalizing the results of this study to all TBI patients.
The study protocol also specified that the portable NIRbased device exam must have been performed within 12 h of head injury. This time requirement for data collection was chosen because the NIR method relies on the absorption characteristics of acute blood. As previous studies have suggested, chronic subdural hematomas cannot be reliably detected with this method , probably because the hemoglobin breakdown products in a chronic hematoma do not have the same absorption characteristics.
Hair, especially when thick and darkly colored, has been a difficult issue complicating past studies using NIR technology to detect intracranial hematomas . Shaving areas of the head to obtain a more accurate NIR examination would be an impediment to clinical application of the device. The fiberoptic lightguides of the NIR device, which can be worked in between hairs, was designed to minimize the significance of this problem.
A limitation of the previous pilot study was that all of the NIR measurements were performed by one experienced investigator using a prototype device that required calibration and manual calculation of the DOD, which would be cumbersome in an emergency setting . The portable NIR device's simplified and dedicated design has made the NIR technique more useful in the setting of the trauma emergency department. Although some training was required to properly do the NIR examination with the portable device, there was no difference in performance among the difference sites participating in the study.
The output of the NIR device gives an indication of the presence or absence of an intracranial hematoma, and a value of DOD in the four brain regions examined. This would not be sufficient information alone to make a definitive diagnosis or to make a decision about treatment. Surgical decisions require additional information about the location, type, and size of the hematoma, as well as other brain characteristics such as midline shift and other indications of mass effect (Bullock et al., 2006) . The findings from the NIR device also cannot detect other traumatic processes such as diffuse axonal injury or cerebral edema. Thus a severe TBI could exist in the presence of a normal NIR exam.
Nevertheless, the high specificity and high NPV of the NIR examination suggest that the device might be useful to supplement clinical information, such as the neurological status, the mechanism of injury, and hemodynamic stability, which are used in the field to triage patients to a Level 1 trauma center, and in the emergency department to determine the urgency and/or the need for subsequent imaging studies. The portability of the NIR device might be particularly useful in military applications and other austere conditions. The NIR technology
FIG. 4.
Positive predictive value (PPV) and negative predictive value (NPV) for all patients, for patients with Glasgow Coma Scale score (GCS) <15, and for patients with NIR exams showing a difference in optical density (OD) >0.2. The combination of the NIRS exam and the clinical neurological examination yielded a better PPV than either characteristic alone (NIR, near-infrared).
cannot replace CT scanning when it is readily available, but the finding of a positive NIR examination might suggest a higher priority for imaging, even in an otherwise low-risk patient. Future studies will be needed to confirm the role of this NIR technology in the screening and treatment of TBI.
LINICAL studies have documented the importance of secondary brain insults in determining neurological outcome after head injury. Delayed intracranial hematomas are one of the most easily remedied causes of secondary injury if identified early but can cause significant disability or death if not promptly recognized and treated. Computerized tomography (CT) scanning has revealed that delayed hematomas after head trauma are more common than had been previously suspected. 3, 7, 10, 11, 14, 18, 22, 26, 28, 29 The incidence of delayed traumatic intracerebral hematoma varies from 2.3% to 8.4% of severely head injured patients. 7, 8, 14, 17, 18, 24, 26, 27 The incidence of delayed epidural hematoma varies from 9% to 23%. 4, 22, 25 Postoperative intracranial hematomas can also occur, with an incidence ranging from 7.8% to 61%. 15, 16, 19, 23 In a recent large series of 850 patients who underwent craniotomy for evacuation of a traumatic hematoma, 88 (10.4%) required a second operation for removal of a second intracranial lesion. 6 Mortality rate and the incidence of a poor neurological recovery are significantly increased in patients who develop delayed traumatic intracranial hematomas. 9, 14, 20, 21, 29 Serial CT scans are the most reliable method for detecting a delayed hematoma. However, CT scans require that patients, many of whom are critically ill, be taken out of the intensive care unit, and the yield is relatively low if serial scans are obtained in all patients. A clinical monitoring technique for accurate selection of patients requiring follow-up CT would improve the yield.
Current clinical monitoring techniques, such as intracranial pressure (ICP) monitoring and serial neurological examinations, are not ideal for detecting delayed hematomas. Patients with delayed hematomas may appear to be relatively normal and later demonstrate sudden neurological deterioration, 29 or they may not exhibit a change in their neurological examination. 1, 9, 14, 25 Intracranial pressure may be normal in up to 20% of patients harboring delayed hematomas that require surgery. 2, 5, 14 The ideal clinical monitor would be capable of making online continuous measurements in the intensive care unit and would identify the development of a hematoma prior to the onset of clinical neurological deterioration. A CT scan could then be performed to obtain more information about the size and location of the hematoma. A previous study demonstrated that near-infrared spectroscopy (NIRS) performed in the emergency room reliably identified the presence of a traumatic intracranial hematoma in each of 40 patients in whom a CT scan also revealed the 
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Early detection of delayed traumatic intracranial hematomas using near-infrared spectroscopy presence of a hematoma. 13 The majority of the hematomas detected were subdural (22) or epidural (10) . Only eight patients had intracerebral hematomas. The difference in absorbance of near-infrared light at 760 nm between the normal side and the side of the brain harboring a hematoma was directly related to the thickness of the hematoma and was specific for acute collections of blood. The purpose of this study was to determine whether NIRS would be useful in identifying the development of delayed intracranial hematomas in patients in the intensive care unit.
Clinical Material and Methods
Patient Characteristics and Management
One hundred sixty-seven patients who were admitted to Ben Taub General Hospital with a moderate (Glasgow Coma Scale (GCS) score [9] [10] [11] [12] or severe (GCS score ≤ 8) head injury were studied with NIRS and CT. The age of the patients ranged from 4 months to 101 years. One hundred forty-one patients were male and 26 were female. The GCS score was 3 to 8 in 77 patients and 9 to 12 in 90 patients.
All patients were evaluated with an initial CT scan and were followed with serial neurological examinations. Patients with GCS scores of less than or equal to 8 also had ICP monitoring. A repeat CT scan was obtained at 24 to 48 hours postinjury. A CT scan was also obtained after the occurrence of neurological deterioration, increasing ICP, or suggestion of an intracranial hematoma by NIRS examination. Indications for surgery were a midline shift greater than 5 mm, intracranial hypertension, or neurological deterioration.
Method of NIRS Examination
An NIRS examination was performed on the patient in the emergency room at the time of the admission CT scan, and then serial measurements were obtained during the hospital course, along with follow-up CT scans. A dual wavelength NIRS unit (RunMan, NIM, Inc., Philadelphia, PA) was used to quantitate hemispheric differences in light absorbance. The NIRS unit is compact, battery operated, and easily transported to the emergency room or intensive care unit. The probe consists of two tungsten filament lamps on either side of a 760-and 850-nm light detector. The 4-cm separation of light source and detector allows measurement of near-infrared light absorbance in a volume of tissue approximately 2 cm wide by 2 to 3 cm deep. The detector measures the intensity of the unabsorbed or reflected light.
The probe of the NIRS unit was placed successively on the frontal, parietal, occipital, parasagittal, and suboccipital regions of the scalp on both sides of the head. The intensity of unabsorbed light at 760 nm was recorded in each of these regions. The difference in optical density (⌬OD) between the hemispheres in each of these regions was calculated by the formula: ⌬OD = log 10 (I N ÷ I H ), where I N is the intensity of the reflected light on the normal side and I H is the intensity of the reflected light on the hematoma side. The maximum ⌬OD among the various regions examined was recorded for each patient.
Statistical Analysis
Data are expressed as the median and range. Differences in median values were compared by Kruskal-Wallis analysis of variance and Dunn's method when multiple comparisons were made. The ⌬OD was compared to the thickness of the hematoma on CT scan by nonlinear regression analysis. A p value of less than 0.05 was considered significant.
Results
Initial Diagnosis: Relationship to ⌬OD
The maximum ⌬OD, measured in the emergency room, correlated with the findings on the initial CT scan. As in the previous study, 13 there were characteristic abnormalities of near-infrared light absorbance found in patients with intracranial hematomas.
Diffuse Brain Injury. The initial diagnosis was diffuse brain injury in 49 of the patients. The median ⌬OD was 0.03 (range 0-0.05) in these patients. The distribution of ⌬OD among these patients is shown in Fig. 1 . These values were not significantly different from those observed in normal adults (0.02 Ϯ 0.01) and previously reported. 13 Intracranial Hematomas. The initial diagnosis included an intracranial hematoma in 118 of the patients. Figure  1 shows the frequency distribution of the ⌬OD obtained in the different types of intracranial hematoma. The ⌬OD in patients with an extracerebral hematoma (subdural or epidural hematoma) was significantly greater than in patients with intracerebral hematomas (p Ͻ 0.001). The ⌬OD in the patients with all types of hematomas was significantly greater than in patients with diffuse brain injury (p Ͻ 0.001).
Thirty-five patients had an epidural hematoma on their initial CT scan. The median ⌬OD was 1.12 (range 0.12-1.60). The thickness of the epidural hematoma on the initial CT scan and the ⌬OD in the emergency room were significantly related (Fig. 2 left; r 2 = 77%, p Ͻ 0.01). The ⌬OD increased with the size of the hematoma up to a thickness of approximately 1.5 cm and then plateaued.
Sixty-two patients had a subdural hematoma on their initial CT scan. The median ⌬OD was 0.82 (range 0.32-1.82). The thickness of the subdural hematoma on the initial CT scan and the ⌬OD in the emergency room were significantly related (Fig. 2 right; r 2 = 46%, p Ͻ 0.01). Fifteen patients had an intracerebral hematoma and six patients had a contusion revealed on the initial CT scan. The median ⌬OD was 0.38 (range 0.29-0.75) with an intracerebral hematoma and 0.18 (range 0.05-0.38) with a contusion. The ⌬OD was not significantly related to the size of the intracerebral hematoma, perhaps because a significant volume of the hematoma was deeper than the 2-cm light penetration afforded by the design of the NIRS probe used in this study.
Delayed Lesions: Relationship to ⌬OD
Late lesions included delayed traumatic intracerebral hematomas (new intracerebral hematoma or coalescence of a preexisting contusion into a hematoma), delayed extracerebral hematomas (new subdural or epidural hema-
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Near-infrared spectroscopy and delayed intracranial hematomas toma or enlargement of a preexisting hematoma), and development of a hematoma at the operative site. Twentyseven (16%) of the 167 patients developed some type of late intracranial hematoma, either an intracerebral (eight patients), extracerebral (six patients), or postoperative hematoma (13 patients). The types of late lesions are summarized in Table 1 .
Diffuse Brain Injury. Three of the 49 patients with diffuse brain injury developed lesions that were not present on the initial CT, at times varying from 2 to 48 hours postinjury. One patient with multiple skull fractures developed an epidural hematoma 2 days postinjury. The ⌬OD in this patient was initially 0, and it gradually increased over a period of 48 hours to 1.42, prompting a CT scan that revealed the epidural hematoma. A second patient developed a delayed traumatic intracerebral hematoma 2 hours after a normal CT scan. The ⌬OD increased from 0.05 to 0.37 over the same 2-hour period. A third patient developed a subdural hematoma and frontal contusion 5 hours after a normal CT scan. The ⌬OD increased from 0.03 to 0.82 over the 5 hours between CT scans. All three late lesions required surgical evacuation.
Epidural Hematomas. Twenty-three of the 35 patients with an initial diagnosis of epidural hematoma had surgical evacuation of the hematoma on admission to the hospital; 12 patients were treated without surgical evacuation because the epidural hematoma was small and localized. Late lesions developed in three of the patients initially treated surgically and in two of the patients initially treated medically. of the epidural hematoma; and delayed development of epidural hematoma on the side opposite the original lesion. Two of these late lesions were surgically evacuated.
In addition, two of the 12 patients who were initially managed medically had significant increases in the size of the epidural hematoma during the early hospitalization, with one patient ultimately requiring surgery. Figure 3 upper shows the average ⌬OD on the admission NIRS examination in the 12 patients who were treated nonsurgically, and the average ⌬OD in the two patients who had enlargement of the epidural hematoma during the hospital course.
Of the five late lesions identified after an initial diagnosis of epidural hematoma, three required surgical evacuation. Two of the late lesions were small and resolved spontaneously.
Subdural Hematomas. Fifty-three of the 62 patients with an initial diagnosis of subdural hematoma had surgical evacuation of the hematoma on admission to the hospital; nine patients were not treated surgically because the subdural hematoma was small and not associated with mass effect. Late lesions developed in 10 of the patients who were treated surgically. Figure 3 center shows the average ⌬OD on the initial scan in all 53 patients who were treated surgically, as well as the average postoperative ⌬OD in the 43 patients with uncomplicated courses, and in the 10 patients who developed some type of postoperative intracranial hematoma that was significantly different (p Ͻ 0.05). These postoperative complications included: recurrence of the subdural hematoma (six patients), epidural hematoma at the operative site (three patients), and delayed traumatic intracerebral hematoma (one patient). Seven of these 10 late lesions were lesions that had to be treated surgically.
The nine patients who were treated medically all had uneventful hospital courses. The NIRS examination revealed a gradual return to normal values for ⌬OD (Fig. 3  center) .
Intracerebral Hematomas or Contusions. Thirteen of the 15 patients in whom an initial diagnosis of intracerebral hematoma had been made received surgical evacuation of the hematoma on admission to the hospital, and two were treated medically. All six patients in whom a contusion was revealed on the initial CT scan were treated medically. Figure 3 lower shows the average ⌬OD on the initial scan in the 13 patients who were treated surgically, as well as the average postoperative ⌬OD in the 10 patients who had uncomplicated courses, and in the three patients who developed some type of postoperative intracerebral hematoma that was significantly different (p Ͻ 0.05). These postoperative complications included recurrence of the intracerebral hematoma (two patients), and epidural hematoma at the operative site (one patient). Two of the three late lesions required surgical evacuation.
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FIG. 3.
Graphs illustrating the distribution of the optical density (⌬OD) in patients with and without late hematomas, after an injury resulting in an initial diagnosis of epidural hematoma (upper), subdural hematoma (center), and intracerebral hematoma or contusion (lower). In each circumstance, the patients who developed late hematomas had significantly higher values for ⌬OD than did patients with uncomplicated courses. In each graph, the box plots show the median of the distribution as a horizontal line across the box. The vertical edges of the box mark the 25th and 75th percentiles and the error bars mark the 10th and 90th percentiles. The closed circles mark any data points outside the 10th and 90th percentiles. ER = emergency room.
In addition, the six patients who initially had a contusion and were treated medically had coalescence of the contusion into an intracerebral hematoma. Three of the six patients required surgical evacuation of the hematoma. Figure 3 lower shows the average ⌬OD on the admission NIRS examination in the six patients who were treated nonsurgically and the average ⌬OD in these patients, who had coalescence of the contusion to an intracerebral hematoma during the hospital course.
Comparison of Changes in ⌬OD to Clinical Monitors. Clearly abnormal changes in ⌬OD (Ͼ 0.3) preceded the detection of the hematoma from clinical signs (change in neurological examination or increase in ICP) or from a routine follow-up CT scan in 24 of the 27 patients who developed a late lesion. On two occasions in patients who developed a recurrent intracerebral hematoma, the ⌬OD increased but not to more than 0.3, and in one patient who had bilateral lesions, the ⌬OD did not change as both lesions increased in size.
An example of the serial changes in ⌬OD that occurred as an intracerebral hematoma, then a postoperative epidural hematoma developed, is shown in Fig. 4 . Summary S. P. Gopinath, et al. 442 J. Neurosurg. / Volume 83 / September, 1995 FIG. 4 . Illustrative case of a patient who developed both intracerebral and extracerebral hematomas. Upper: Graph illustrating the entire sequence of events. Center: Serial computerized tomography (CT) scans. Lower: Drawings showing the near-infrared spectroscopy (NIRS) examination at the time of the CT scan. This patient was admitted to the hospital with a Glasgow Coma Scale score of 6 after an auto-pedestrian accident. A CT scan obtained at the time of admission revealed a left frontoparietal contusion. He was monitored, and 8 hours later the NIRS suggested the development of an intracranial hematoma. A CT scan was obtained and demonstrated a large left frontal intracerebral hematoma. He was taken to surgery and the hematoma was evacuated. Postoperatively, the optical density returned to normal values, but then gradually increased over several hours. A repeat CT scan on the 2nd postoperative day showed an epidural hematoma, which was surgically evacuated.
graphs demonstrating these changes in all 27 patients are shown in Fig. 5 .
Neurological Outcome
Outcome was graded according to the Glasgow Outcome Scale and was assessed at 3 months or more postinjury. Eighteen (67%) of the 27 patients had a favorable outcome (good recovery and moderate disability), whereas nine patients (33%) had a poor outcome (severe disability, vegetative state, and death). Of the 18 patients with a surgical lesion identified by the NIRS, 12 (67%) had a favorable outcome and six (33%) had a poor outcome.
Discussion
The 16% incidence of delayed traumatic hematomas in the present study was comparable to that reported in the literature. The primary difference in the present study was the identification of the delayed hematomas at a relatively early time, prior to any neurological consequences in the majority of patients. The hematomas were identified as early as 2 hours, and as late as 72 hours after admission. Even if serial CT scans had been performed on every patient within the first 24 hours postinjury, no more information would have been obtained than with the serial NIRS examinations. The NIRS examination was successful in detecting intracerebral as well as subdural and epidural hematomas.
Earlier identification and treatment of intracranial hematomas should prevent one cause of secondary injury, resulting in a better neurological outcome. This study was not a randomized trial, and caution should be taken in comparing studies with possibly differing entry criteria and severities of injury. Nevertheless, the 67% incidence of favorable outcomes in the current series was better than might have been expected based on previous reports. Mortality rates of 36.5% to 50% have been reported for delayed traumatic intracerebral hematoma. 9, 14, 20, 21, 29 Postcraniotomy hematomas have been reported to result in a poor outcome in nearly two-thirds of patients. 6 One possible explanation for the better outcome in the present study could be that hematomas that would not have resulted in subsequent neurological deterioration were identified. This is not likely because the incidence of hematomas is similar to previous studies, and because the outcome was better even if patients with only surgical lesions were examined.
There are several potential limitations in the identification of intracranial hematoma using NIRS in its current form. The location of the hematoma cannot be precisely determined. Intracerebral hematomas tend to absorb light less intensely than extracerebral hematomas, but there is some overlap. A CT scan must be obtained to gather information necessary to make surgical decisions.
Because the NIRS examination relies on comparison of light absorption of normal brain to the hematoma, bilateral hematomas might not be detected. One patient in the present series had enlarging bilateral temporal lesions that did not change the ⌬OD. The NIRS delineates the edges of the hematoma; therefore an adjacent unaffected area could be used as a reference site.
Because the NIRS examination relies on light absorption by hemoglobin, initially in the oxy form and subsequently in the met form, the eventual metabolic products of hemoglobin that may occur in chronic subdural hematoma would not be detected. In a previous report, the light absorbance was found to be increased, decreased, or not changed on the side of a chronic subdural hematoma. Patients who developed a hematoma after having a normal computerized tomography scan initially (upper), had normal ⌬OD on the emergency room examination but developed increasing ⌬OD during the hospitalization. Patients who had enlargement of a preexisting lesion (center) had elevated ⌬OD in the emergency room, followed by increasing values during the hospitalization. Patients who developed a new hematoma after craniotomy for a traumatic hematoma (lower) had initially high ⌬OD values on the emergency room examination, normal ⌬OD immediately postoperatively, then gradually increasing ⌬OD during the hospitalization. In each graph, the box plots show the median of the distribution as a horizontal line across the box. The vertical edges of the box mark the 25th and 75th percentiles and the error bars mark the 10th and 90th percentiles. The closed circles mark any data points outside the 10th and 90th percentiles. ER = emergency room.
With the probe configuration that was used in these studies, the mean depth of brain examined was not more than 2 to 2.5 cm; thus, the relationship between ⌬OD and the thickness of the extracerebral hematomas plateaued at a thickness of approximately 1.5 cm. In addition, an intracerebral hematoma more than 2 cm below the surface of the brain would not be detected with this probe configuration. The separation of the optical detectors and the light source could be readily widened to increase the depth of the brain that could be examined.
Near-infrared spectrosocpy has promise as a technology that will allow early identification and treatment of intracranial hematomas. Development of the technology may improve the resolution and depth of the NIRS examination. The Regulatory Flexibility Act requires Agencies to analyze regulatory options that would minimize any significant impact of a rule on small entities. Because this rule does not impose any significant costs, we certify that it will not have a significant economic impact on a substantial number of small entities.
Section 202(a) of the Unfunded Mandates Reform Act of 1995 requires that Agencies prepare a written statement, which includes an assessment of anticipated costs and benefits, before proposing ''any rule that includes any Federal mandate that may result in the expenditure by State, local, and tribal governments, in the aggregate, or by the private sector, of $100,000,000 or more (adjusted annually for inflation) in any one year.'' The current threshold after adjustment for inflation is $136 million, using the most current (2010) Implicit Price Deflator for the Gross Domestic Product. We do not expect this rule to result in any 1-year expenditure that would meet or exceed this amount.
IV. Paperwork Reduction Act of 1995
We have concluded that this direct final rule contains no collection of information. Therefore, clearance by the Office of Management and Budget under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520) is not required.
V. Environmental Impact
We have determined under 21 CFR 25. 33 that this direct final rule is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.
VI. Federalism
We have analyzed this direct final rule in accordance with the principles set forth in Executive Order 13132. We have determined that this direct final rule does not contain policies that have substantial direct effects on the States, on the relationship between the National Government and the States, or on the distribution of power and responsibilities among the various levels of government. Accordingly, we have concluded this direct final rule does not contain policies that have federalism implications as defined in the Executive order and, consequently, a federalism summary impact statement is not required.
VII. Comments
Interested persons may submit to the Division of Dockets Management (see ADDRESSES) either electronic or written comments regarding this document. It is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document, and they may be accompanied by a supporting memorandum or brief. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.
List of Subjects in 21 CFR Part 20
Confidential business information, Courts, Freedom of information, Government employees.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 20 is amended as follows: C. 241, 242, 242a, 242l, 242n, 243, 262, 263, 263b-263n, 264, 265, 300u-300u-5, In accordance with section 513(f)(2) of the FD&C Act, FDA reviewed the petition in order to classify the device under the criteria for classification set forth in section 513(a)(1) of the FD&C Act. FDA classifies devices into class II if general controls by themselves are insufficient to provide reasonable assurance of safety and effectiveness, but there is sufficient information to establish special controls to provide reasonable assurance of the safety and effectiveness of the device for its intended use. After review of the information submitted in the petition, FDA determined that the device can be classified into class II with the establishment of special controls. FDA believes these special controls will provide reasonable assurance of the safety and effectiveness of the device.
The device is assigned the generic name Near Infrared (NIR) Brain Hematoma Detector, and it is identified as a noninvasive device that employs near-infrared spectroscopy that is intended to be used to evaluate suspected brain hematomas.
FDA has identified the following risks to health associated with this type of device and the measures required to mitigate these risks: FDA believes that the following special controls address these risks to health and provide reasonable assurance of safety and effectiveness: (1) Following the effective date of this final classification rule, any firm submitting a 510(k) premarket notification for an NIR Brain Hematoma Detector will need to comply with the special controls named in the regulation.
Section 510(m) of the FD&C Act provides that FDA may exempt a class II device from the premarket notification requirements under section 510(k) of the FD&C Act, if FDA determines that premarket notification is not necessary to provide reasonable assurance of the safety and effectiveness of the device. For this type of device, FDA has determined that premarket notification is necessary to provide reasonable assurance of the safety and effectiveness of the device. Therefore, this device type is not exempt from premarket notification requirements. Persons who intend to market this type of device must submit to FDA a premarket notification, prior to marketing the device, which contains information about the NIR Brain Hematoma Detector they intend to market.
II. Environmental Impact
The Agency has determined under 21 CFR 25.34(b) The Regulatory Flexibility Act requires Agencies to analyze regulatory options that would minimize any significant impact of a rule on small entities. Because reclassification of this device from class III to class II will relieve manufacturers of the device of the cost of complying with the premarket approval requirements of section 515 of the FD&C Act (21 U.S.C. 360e), and may permit small potential competitors to enter the marketplace by lowering their costs, the Agency certifies that the final rule will not have a significant economic impact on a substantial number of small entities.
Section 202(a) of the Unfunded Mandates Reform Act of 1995 requires that Agencies prepare a written statement, which includes an assessment of anticipated costs and benefits, before proposing ''any rule that includes any Federal mandate that may result in the expenditure by State, local, and tribal governments, in the aggregate, or by the private sector, of $100,000,000 or more (adjusted annually for inflation) in any one year.'' The current threshold after adjustment for inflation is $136 million, using the most current (2010) Implicit Price Deflator for the Gross Domestic Product. FDA does not expect this final rule to result in any 1-year expenditure that would meet or exceed this amount. Introduction-Intracranial hematomas are a treatable cause of secondary brain injury in patients who have sustained head trauma. They have been reported to occur as the primary injury in 40% of patients with severe head injury. Additionally, recurrent hematomas and other delayed hematomas have been estimated to develop in up to 23% of that patient population 1 . Successful treatment relies upon diagnosis and intervention prior to neurological deterioration. Serial computed tomography (CT) examinations are the current clinical standard examination for detection of intracranial hematomas. However, serial CT is not practical or available in all cases, typically requires transport to the scanner, and can involve significant radiation exposure. To address the need for a noninvasive and portable means of detecting intracranial hematoma, the Infrascanner (Infrascan Inc., Philadelphia PA) was developed. Concomitant to a greater concentration of hemoglobin in acute hematoma 1 , the observation that extravascular blood absorbs near infrared (NIR) light more than normal brain tissue is the basis for this technology. Funding for development of the device has been provided in part by the Office of Naval Research. Methods and Materials-One Infrascanner device was placed in service at the Camp Fallujah Surgical Facility beginning January 2008 with the intent of familiarizing clinicians with the use of the device and demonstrating ease of operation and potential utility. It was operated by the Shock Trauma Platoon (STP) of Combat Logistics Battalion 1 commencing February 2008. Infrascanner examinations were administered only when prescribed by attending clinicians. All clinicians were informed that the device was not FDA approved and that it was available for clinical use but not for the conduct of research. As of May 10, 2008 , a retrospective review of the Infrascanner usage by the STP revealed that it had been used to examine approximately 100 USMC and USN personnel as well as others who presented with closed head injury. Approximately 12 service personnel who had sustained at least one improvised explosive device (IED) blast were included. Results-Experience with the Infrascanner device suggested that it offered potential utility in prioritization of referrals for CT and for further treatment. The device was widely viewed as easy to use and to maintain. Training to use the device is straightforward and can be accomplished using normal volunteers as control subjects. There were no false positive findings during the period of use of the device. In two instances hematoma was detected, leading to surgical intervention. One of these involved a patient with pre-existing subdural hygromas who experienced a transformation to subdural hematoma after striking his head on an airplane overhang. A second positive finding was obtained in an Iraqi policeman whose vehicle overturned leading to subdural hematoma and temporal contusion. Regardless of a negative NIR finding approximately 10% of patients were referred for CT per standard clinical practice, in cases involving loss of consciousness, significant trauma, and damage above a threshold to protective equipment or vehicles. All patients with a negative NIR scan also had a negative CT scan of the head. Discussion-Two CT scanners are available in the AO (Baghdad and Balad), and the use of either requires evacuation from Fallujah, usually by air, with attendant risk and significant expense. The Infrascanner located in Fallujah provides immediate information that is not available by any other means, and offers life-saving potential in the prioritization of patients who require immediate surgical intervention. Negative findings can aid in the diagnosis and treatment decision process that requires consideration of the significant dangers of transport to an imaging facility. Use of the Infrascanner device was viewed positively by clinicians as providing useful information under circumstances of limited diagnostic imaging. All attending clinicians understood the value of the device as a triage tool complementing clinical observations. It was specifically not used as a replacement for CT. Anecdotal responses include that of a psychiatrist who has requested that his patients be tested, especially those in the acute period following exposure to traumatic injury. Development of a ruggedized version of the Infrascanner as well as continued evaluation and eventual approval by regulatory authorities will further potentiate the battlefield utility of the device. Applications aboard ships and in remote locations should similarly be both feasible and desirable. (TBI) is a leading cause of death and disability and a major public health problem in the US, Canada [1] [2] [3] and Europe [4, 5] . Main causes of TBI are traffic accidents [6] , work and sports-related accidents [7, 8] and violence [9, 10] . Patients with TBI usually show physical and neuropsychological sequelae in the post-acute phase [11] [12] [13] . Different studies indicate that early diagnosis, management and care in the acute setting minimizes the impact of secondary injury, one of the most prominent causes of a patient's deteriorating condition [14, 15] . Morbidity and outcome are narrowly associated with the quality of emergency care. Delayed medical attention is the strongest independent predictor of mortality in TBI patients. Quick emergency team activation should be a priority for hospitals operating rapid response systems [16] .
IV. Federalism
Early detection and surgical evacuation of massoccupying lesions have decreased mortality and improved outcome in these patients. This reduction in mortality and morbidity requires rapid identification of the patient's cerebral and cranial status. A study by Seelig et al. [17] reports on the importance of taking action within the first 4 hours post-injury. Any further delay in haematoma evaluation severely increases mortality and worsens functional outcome in patients who survive.
To date, the Computerized Axial Tomography (CT) is the gold standard for identification and localization of haematomas due to TBI. Although rapid initial assessment of a TBI patient is crucial, CT scans are not always available at the moment of trauma or vascular event. In most cases, the patient must wait until arrival at a hospital with a radiology department. Added to this is the difficulty of rescuing certain patients that have suffered a TBI. Consider cases where access to the individual is difficult or more common cases of traffic accidents where the state of the vehicle impedes safe removal of the victim. Any clinical assessment prior to arrival at a hospital must be done in situ by emergency personnel. Haematoma assessment within the critical 4-hour period could be achieved by means of an organized system of patient assistance, with two fundamental elements: emergency action protocols and coordination among professionals who care for the patient.
The time devoted to assisting patients who may suffer TBI is usually shorter in accidents that take place in urban or metropolitan areas. Once the person with neurological damage is stabilized, the procedure usually includes a CT scan, followed by neurosurgery, if necessary. However, in emergencies with TBI victims in rural areas or areas with difficult access, such as conflict or natural disaster zones, it is more difficult and will ultimately take longer to determine which persons require neurosurgery. The time between injury and treatment could be reduced if the assessment to detect intracranial haematoma is done in situ.
The method normally used to clinically identify intracranial haematomas in situ is the neurological evaluation. However, this test is not as sensitive as the CT scan, especially since no observable physical signs exist to assure the presence of an intracranial haematoma. The principle signs recognized by neurological methods are only present in a fraction of patients. For instance, coma is present in 56% of TBI patients without a haematoma [18] .
Near-Infrared Spectroscopy (NIRS) could improve existing methods of identification of intracranial haematomas in these patients in situ. This instrument is characterized by its small size, portability and overall low cost. A clinical instrument which uses NIRS technology is currently being developed (Infrascanner). This device is designed to minimize size and thus increase its portability. The exam lasts 3 minutes and is easy to use in assessment applications as well as data organization and transmission. The Infrascanner provides information that could be useful in initial evaluations of patients with possible brain injury (i.e. at the site of the accident or in emergency rooms where CT scans are not immediately available).
The purpose of this pilot investigation was to evaluate the Infrascanner as a handheld medical screening tool for the detection, in situ, of brain haematomas in patients who have sustained a head injury. The validity of the device was studied, particularly its sensitivity and specificity, as well as its positive and negative predictive values as compared to those of CT scans. This study was also designed to evaluate the Infrascanner's classification accuracy in detecting different kinds of haematomas, namely intra-axial and extra-axial haematomas. These usually differ in topographical representation and depth and, hence, a NIRS-based system may vary in detection accuracy. Another aim of this study was to assess the Infrascanner's sensitivity in detecting haematomas that require neurosurgery and smaller haematomas which do not [19, 20] , as well as its detection capacity as post-injury time increases, given that within 24 hours haemoglobin starts to metabolize into methaemoglobin and its absorbance characteristics change [21, 22] .
Methods
Patients
This study originally included 38 TBI patients. One patient, whose CT scan revealed a spontaneous intracerebral haemorrhage, was discarded from further analysis. Two additional patients were excluded, one due to massive scalp wounds and a second whose CT scan showed frontal mega sinus. The final sample included 29 males and six females, ranging in age from 17-76 (M ¼ 47.6) . TBI causes included 18 falls, 12 road traffic accidents, two assaults and three additional causes (e.g. animal attack). Glasgow Coma Scale (GCS) was collected at the time of the NIRS exam. Table I shows patients' demographics and clinical characteristics. The mean time between NIRS exam and hospital admission was 12.8 hours (range: 1.97-24.9 hours). The mean time between NIRS exam and CT scan was 5.66 hours (range from 30 minutes to 14.5 hours).
fNIRS algorithm
The Infrascanner TM NIRS device (InfraScan, Inc., Philadelphia, PA) is used for haematoma detection in patients sustaining TBI. The device uses light sensors to contact the scalp surface and calculate optical density in brain regions. This data acquisition protocol consists of eight measurements: four symmetrical pairs of measurements over frontal, temporal, parietal and occipital locations (see Figure 1) . The exam, usually lasting 3 minutes, covers common locations for traumatic haematomas.
For haematoma detection, NIRS uses the principle that extravascular blood absorbs more NIRS light than intravascular blood since there is a greater concentration (10-fold) of haemoglobin in the acute haematoma than in the brain tissue where blood is contained within vessels. Therefore, the absorbance of NIRS light is greater (and reflected light absorbance is lower) on the side of the brain containing the haematoma.
The difference in optical density (DOD) in the different areas is calculated using the following formula:
DOD ¼ log 10 I N I H where I N ¼ the intensity of reflected light on the normal side and I H ¼ the intensity of reflected light on the haematoma side. This system includes two main components: a NIRS-based sensor and a wireless personal digital assistant (PDA). The sensor includes a safe Class I NIRS diode laser, optically coupled to the patient's head by means of two disposable light guides in a 'hairbrush' like configuration. This configuration allows the sensor to contact the skin of the scalp. The 4.0 cm separation between light source and detector allows NIRS absorbance measurement in tissue volume with $2 cm of Figure 1 . Location and procedure for Infrascanner data acquisition in patients with suspected brain injury. width and 2-3 cm of depth. The light source uses an 808 nm wavelength. The detector is covered by a band pass filter to minimize interference from background light. Electric circuitry is also included to control laser power and detector signal amplifier gain. Signals acquired from the detector are digitized and transmitted by a wireless link to the PDA. This link is also used to receive and set the sensor's hardware parameters. The PDA receives the data from the sensor and automatically adjusts its settings to ensure good data quality. The data is further processed and the results are displayed on the PDA screen ( Figure 2 ). Intracranial haematoma detection was established when a DOD > 0.2 units occurred in a particular pair of bilateral measurements. When a measurement indicated a difference of AE0.2 OD or greater, the measurement pair was repeated twice to confirm the presence of a haematoma. A DOD 0.2 units was considered a negative exam. The 0.2 cut-off for the Infrascanner was set following a previous study on haematoma detection using NIRS [23] . This study showed that the DOD range varies among different types of haematomas. For instance, the DOD range for intracerebral haematomas was 0.1-0.8, with a maximal sensitivity of 0.3. However, 40% of these haematomas showed DOD below 0.3 (only 13% fell below 0.2). DOD range for epidural haematomas was 0.6-1.6, with a maximal sensitivity of 1.3. Maximal sensitivity for subdural haematomas was 0.7 (range 0.5-1.6). Based on these results, >85% of intracranial haematomas can be detected using a 0.2 cut-off.
Procedure
This study was performed on patients admitted to the Neurosurgical ICU (22 beds) and the Emergency Room Observation Unit (42 beds) at the Virgen del Rocio University Hospital, Seville, Spain (a Level 1 trauma centre). The Hospital Institutional Review Board approved this study and all procedures were in accordance with the Declaration of Helsinki guidelines. Figure 3 shows the study's inclusion protocol for patients with TBI. Briefly, after admitting a patient suspected of having an intracranial haematoma, emergency doctors requested a CT scan and an Infrascanner exam. In some cases, the Infrascanner exam was performed after the CT scan for medical reasons. An experienced neuroradiologist, blind to the study goals and NIRS data, evaluated the CT scans. NIRS exams were performed by trained hospital personnel, also blind to CT scan results. Finally, all patients were managed according to Brain Trauma Foundation guidelines and local protocols.
Haematoma characteristics, including type, volume (gauged in mL) and distance from brain surface, were also recorded. The GCS score was collected at baseline and during each NIRS assessment. NIRS accuracy indexes in haematoma detection were first calculated using CT scan results as the comparative gold standard. A CT scan with hyperdense images was considered pathological.
Overall sensitivity and specificity analyses were performed, using comparisons between NIRS and CT scan results. True positives, false positives, true negatives and false negatives were counted and used to estimate both sensitivity (true positives/true positives þ false negatives) and specificity (true negative/ false positive þ true negative). Positive predictive values (PPV ¼ true positive/true positive þ false positive), negative predictive values (NPV ¼ true negative/true negative þ false negatives) and their respective 95% confidence intervals (CI) were also calculated. Subsequent analysis included estimating NIRS classification accuracy indexes for intra-axial haematomas (intraparenchymal and intraventricular haematomas), extra-axial haematomas (subdural, epidural and subarachnoid haemorrhages), nonsurgical intracranial haematomas (volume < 25 mL) and NIRS exams taken before and after 12 hours post-TBI. 
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Results CT lesions were represented as follows (n): negative CT (16), intraparenchimal haematoma (7), subdural haematoma (4), epidural haematoma (2), subarachnoid haemorrhage (3), subarachnoid haemorrhage þ subdural haematoma (2), intraparenchimal haematoma þ epidural haematoma (1) . Figure 4 shows four pathological CTs of intracranial haematomas detected by Infrascanner in the study sample.
Overall accuracy indexes obtained from the TBI patient group showed that the Infrascanner achieved 89.5% sensitivity and 81.2% specificity. PPV was 85% and NPV was 86.7%. The Infrascanner could detect 90% of extra-axial haematomas and 88.9% of intra-axial haematomas (Table II) .
The Infrascanner exam detected 93.3% of existing non-surgical haematomas (n ¼ 15). PPV for this classification was 82.3% (Table III) .
Finally, 87.5% sensitivity was found when the Infrascanner exam was performed within the first 12 hours post-trauma, whereas exams taken after 12 hours post-trauma showed 90.1% sensitivity (Table IV) .
Discussion
The most significant results of this pilot study are that the handheld near-infrared Infrascanner demonstrates high sensitivity and specificity in detecting intra-and extra-axial hemorrhagic haematomas and, even more importantly, it is able to detect small haematomas (<25 mL) within the first 24 hours following injury. Data shows that the Infrascanner achieves 89.5% sensitivity when used on patients with TBI. Its on-site capacity to identify patients that have suffered an intracranial haematoma may be considered very high. The Infrascanner also shows excellent specificity (81.2%) or the capacity to detect true negatives, identifying patients with TBI that have not suffered an intracranial haematoma. When compared to gold standard CT scans, its probability of positive predictive value is 85% and 86.7% for negative predictive value. This means that the Infrascanner is very accurate when confirming the presence or the absence of a haematoma. The data also illustrates the Infrascanner's excellent capacity to identify both intra-axial and extraaxial haematomas. Its sensitivity for extra-axial haematomas was 90% and 88.9% for intra-axial haematomas. The Infrascanner was excellent at detecting extra-axial (epidural, subdural and sub-arachnoid haemorrhage) as well as intra-axial haematomas during the acute phase of TBI. The predictive values were very accurate, given that the prevalence of intracranial haematomas in this sample was 54.3% and well distributed between intra-axial (25.7%) and extra-axial (28.6%). In some cases, the Infrascanner detected intra-axial haematomas over 3 cm deep. This is unusual, given that the distance between the Infrascanner's light source and detectors should limit detection to a depth of 3 cm. Some authors [24] suggest that oedematous tissue between the haematoma and the NIRS light source and detectors could make the optical density measure surpass 0.2.
The volume of a haematoma is the single strongest predictor of outcome. Thus, it is relevant to report that the Infrascanner is highly sensitive (93.3%) to small haematomas (<25 mL). It would be of great interest to provide accuracy results for large haematomas (>25 mL). However, in this sample, the prevalence of haematomas this large was too low (11.42%) for valid accuracy analyses with representative data.
The Infrascanner, while not designed to substitute CT scans, may be useful in places or situations 2-99.6) where CT scans are not available. This is especially important given that suspicion of early progressive haemorrhage occurs in almost 50% of patients with head injury who undergo CT scanning within 2 hours of injury, particularly those with cerebral contusions [25] . The Infrascanner was also able to detect brain haematomas in this patient sample after 12 hours post-injury. Recent evidence shows that haematoma expansion is associated with early neurological deterioration [26] ; 38% of patients suffer intracerebral haematoma growth during this time period and it has been related to a worse prognosis. The Infrascanner may be an adjunct tool for quick, periodic monitoring of patients with suspected brain lesions.
A limitation to the present study could be the Infrascanner's current configuration. The location of the haematoma must be precisely determined and, to obtain accurate measurements, the Infrascanner's fibre-optic light guides must be carefully positioned on the scalp. Since scalp haematomas may cause false positive NIRS readings, the head scanning protocol avoids measurements through scalp haematomas, measuring near, but not in, scalp injuries. In this study, sub-galeal haematomas, easily detected in a physical examination, were not problematic, given that with the 3 cm separation between light source and detector, superficial blood on the scalp did not absorb as much light as did deeper intracranial blood.
These results included two false negatives. The first was a 26-year-old male admitted to the ICU with a GCS of 14. A CT scan revealed a traumatic right fronto-temporal haematoma, causing a mass effect and a volume of 33 cm 3 . The patient also suffered a small left frontal hemorrhagic contusion. During the Infrascanner exam, the patient was very agitated and tended to move his head, which could distort the measure. The other patient, a 62-year-old female, was admitted to the ICU with a GCS of 15 after hitting her head on the floor during a fainting spell. A CT scan revealed a small subarachnoid haematoma in the occipital lobe, which had penetrated the cerebral falx. The location of the haematoma and its small size could have made it difficult for Infrascanner detection. In any case, studies have reported that in some cases ($10%), the optical signal of NIRS methods is insufficient, due to various, mostly anatomical, reasons [27] . This could be the case in these false negative results.
This study demonstrates that the Infrascanner is a useful tool in the initial examination and screening of patients with head injury. It has proven utility as an adjunct to CT scans or as a preliminary exam given within 24 hours post-injury, when a CT scan is not available. The Infrascanner's high specificity and high NPV suggest that the device could supplement clinical information, such as neurological status, mechanism of injury and hemodynamic stability, all of which are used in the field to triage patients to a trauma centre and in the emergency unit to determine the urgency and/or need for subsequent imaging studies. The Infrascanner is not designed to substitute a CT scan, nor can the NIRS technology replace CT scanning when it is readily available. However, a positive NIRS exam could give higher priority for imaging, even in an otherwise low risk patient, particularly in cases where the detection is made prior to hospitalization.
In conclusion, the data show that the Infrascanner is a sound portable device for detecting pre-operative intracranial subdural, epidural and subarachnoid haematomas in intensive care fields and emergency care units. It could aid paramedics, emergency room physicians and hospital staff, permitting earlier treatment and reducing secondary injury caused by present and delayed haematomas. It would be interesting to test the Infrascanner in the ICU to determine if periodic NIRS measures can be used to monitor the post-operative development of intracranial haematomas.
Declaration of interest:
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
The Utility of Near Infrared Spectroscopy in Detecting Intracranial Hemorrhage in Children
Introduction H ead injuries are a common reason for emergency department (ED) visits and hospital admissions in children. In the United States, childhood blunt head trauma accounts for *650,000 ED visits, 50,000 hospitalizations, and 3000 deaths annually (Centers for Disease Control and Prevention, 2000,2002) . Traumatic brain injury (TBI) from these insults, either accidental or inflicted, accounts for more than 70% of fatal childhood injuries. Evaluation and assessment of children in the ED can be difficult, and brain injuries that are subtle or without external signs of trauma can go undetected. Rapid triage and assessment of victims of suspected TBI is crucial to determine if underlying brain injury exists, and to further prevent secondary neurologic injury that could increase overall morbidity and mortality.
For infant/children victims of closed head injury (blunt head trauma or abusive head trauma [AHT]), there are compelling reasons to develop a sensitive tool to detect intracranial hemorrhage (ICH) . In this population, the history provided by the caretaker may be unreliable and the patients are generally non-verbal. The neurological examination is limited and the Glasgow Coma Scale (GCS) score (the most widely used objective measure of mental status in TBI) has not been validated. No single physical sign reliably indicates the presence of an ICH, and focal neurological findings are found in only a fraction of patients with surgical hematomas (Greenes and Schutzman, 1999; Schutzman et al, 2001 ). Typical presentations of infants and young children with ICH are non-specific and include fussiness, vomiting, seizures, lethargy, and poor feeding. A unilateral dilated pupil is the most reliable lateralizing sign when it occurs in a child with a hematoma. However, the presence of this finding does not clearly identify the presence of a surgical hematoma and is often a late finding signaling herniation (Chestnut et al., 1994) . Computed tomography (CT) is the gold standard for identification and localization of intracranial pathology in trauma victims, and ICH is a common CT finding in this setting. Early JOURNAL OF NEUROTRAUMA 29:1047 -1053 (April 10, 2012 ª Mary Ann Liebert, Inc. DOI: 10.1089/neu.2011.1890 detection of ICH can improve triage and allow earlier institution of central nervous system (CNS)-directed therapies that can minimize secondary brain injury and improve outcome. Moreover, missed diagnoses of ICH can have catastrophic consequences. Unfortunately, CT scans represent an imaging modality that is not without risk.
The frequency and use of CT has increased dramatically in the past decade. Coren and associates (1998) reported a 63% increase in requests for pediatric CT scans from 1991-1994 in the U.S., and in the decade from 1995-2005 CT use more than doubled (Kupperman et al., 2009 ). Brenner and colleagues (2001) reported that roughly 600,000 abdomen and head CT studies are performed annually in children < 15 years of age in the U.S., and that of these individuals, *500 will die from a radiation-related malignancy. In order to minimize radiation exposure while not missing cases of ICH, Kupperman and coworkers (2009) validated a prediction rule to help identify children at low risk of clinically-important TBI.
Thus, research has focused on non-radiation-based methods of detection of ICH, including ultrasound (Veyrac et al., 1990) , biomarkers (Hergenroeder et al., 2008; Kochanek et al., 2008) , clinical decision rules (Kupperman et al., 2009; Osmond et al., 2010) , and near infrared spectroscopy (NIRS). Ultrasound is a useful modality to diagnose intraventricular hemorrhage (IVH) in infants when the anterior fontanelle is still open, but it loses its utility in older infants and children. Biomarkers such as S100b and neuron-specific enolase (NSE) have been identified, and are increased in the serum and cerebrospinal fluid (CSF) of pediatric patients after TBI (Berger et al., 2002 (Berger et al., ,2009 Haqqani et al., 2007; Shore et al., 2007) , but these biomarkers have not made it into the clinical arena yet. NIRS is a technique that affords the clinician the opportunity to rapidly assess a patient for the presence of ICH. Of potential relevance, NIRS technology, if shown to be useful, represents a painless, portable, and radiation-free tool.
The principle used in identifying ICH with NIRS is that extravascular blood absorbs NIR light more than intravascular blood, since there is a greater (usually 10-fold) concentration of heme-based proteins such as hemoglobin in the acute hematoma than in the brain tissue, where blood is contained within vessels. Acute hematomas or hemorrhages thus lead to changes in the optical density (OD) of infrared light absorption versus normal brain in the contralateral hemisphere. Consequently, ICH can then be detected by the difference in optical density, DOD.
In adults, NIRS technology can diagnose ICH on presentation, as well as late hematomas that develop Zang et al., 2000) . Although the type of hematoma (subdural [SDH] versus epidural [EDH] ) cannot be determined, the presence of any hematoma would be useful to triage a patient for CT scanning.
The prior adult data Zang et al., 2000) suggest that this goal is feasible with NIRS. In initial studies, the sensitivity for identification of traumatic extracerebral (EDH and SDH), and intracerebral hematomas, was 100% and 98%, respectively ). Another study showed that the DOD was highly predictive of findings on head CT, specifically for SDH, EDH, and intracerebral hematomas, and that the DOD occurred prior to increases in intracranial pressure (ICP) or changes in the neurologic examination . Robertson and associates (2010) also reported a sensitivity of 68.7% and a specificity of 90.7% in detecting ICH, and supported the potential utility of NIRS in TBI triage. This is the first study to evaluate the feasibility of using NIRS in the pediatric population, and to describe the sensitivity and specificity of NIRS for identifying ICH exclusively in children. We hypothesized that NIRS would be successful in discriminating between children with and without ICH as diagnosed on head CT.
Methods
This study was approved by the University of Pittsburgh Institutional Review Board (IRB), and consent was obtained from the parents of all children enrolled, and assent was also obtained from capable study subjects. Children 0-14 years of age who were admitted to the pediatric intensive care unit (PICU) and had received a head CT scan as part of their routine clinical care were eligible for inclusion in this study. Exclusion criteria included known pre-existing abnormalities on previous imaging studies, presence of internalized CSF diversion devices that might unblind the investigator to abnormalities (e.g., ventriculo-peritoneal shunt), or skin abnormalities that would limit the ability of the NIRS device to contact the skin (e.g., open lacerations).
Demographic data were collected, including age, sex, race, hair color, past medical history, reason for head CT scan, mechanism of injury if any (e.g., fall or motor vehicle accident), physical examination findings, and results of head CT scan. Information about hair color was collected since darker hair color may be associated with alterations in light absorption and may affect NIRS results. Prior to NIRS determinations, children were stratified into two groups based on CT findings: normal and abnormal. Since the IRB required different consent forms for children with normal and abnormal neuroimaging, and the person obtaining consent was the same as the person performing the NIRS, the operator of the NIRS device knew whether the subject had a normal or abnormal head CT, but was blinded to the nature of the abnormality identified on CT. Children with abnormal imaging were further divided into two groups: (1) those with abnormalities within the brain parenchyma (contusions, diffuse axonal injury, or cerebral edema) or skull fractures; and (2) those with extra-axial collections of blood, defined as blood within the skull but outside the brain. For this study, ICH was defined as hemorrhage within the epidural (EDH), subdural (SDH), or subarachnoid (SAH) space exclusively. Children with punctate hemorrhages (more consistent with DAI) were not considered to have ICH for this study. All CT scan results were obtained from the dictated report from the attending pediatric neuroradiologist uninvolved with this study.
Near-infrared spectroscopy data processing and data collection A commercially-available NIRS device was used based on the manufacturer's instructions (InfraScan, Philadelphia, PA) . This device included a sensor and mobile computing platform for data collection and processing. The sensor included a safe Class I near-infrared diode laser, optically coupled to the patient's head through two disposable light guides. This allows for adequate sensor contact in areas with and without hair. The sensors were placed 4 cm apart with one acting as a light source and the other as a detector of absorbance. The light source uses a 760-nm wavelength, and the detector was covered by a band-pass filter around this wavelength to minimize background light interference. Acquired signals from the detector were digitized and transmitted by a wireless link to the mobile computing platform.
For this study, four regions of the brain were examined bilaterally (frontal, temporal, parietal, and occipital; Fig. 1 ). Absorbance of light was measured and the device determined the OD within the various regions, and DOD of the various regions was electronically calculated using the following formula:
In this formula, I N is the intensity of reflected light on the presumed normal side, and I H is the intensity of reflected light on the presumed abnormal side. Based on previous studies , a DOD > 0.2 was considered abnormal for this study. Negative DOD values were reported with rightsided abnormalities; positive DOD values represented leftsided abnormalities. NIRS measurements were performed on all children in the eight previously described locations within 24 h of imaging, and abnormal DOD values were confirmed a second time. In subjects with abnormal CT scans, data were collected on the results of the imaging study (type of abnormality, presence or absence of ICH, size of ICH, depth of ICH from scalp, type of hemorrhage [SDH, EDH, or SAH], or intraparenchymal hemorrhage), the location of the hemorrhages, and the presence or absence of scalp swelling.
Statistical analysis
The sensitivity (proportion of ICH correctly identified as such), specificity (proportion of non-ICH correctly identified), positive predictive value (PPV, the probability that a positive test is a true positive), and negative predictive values (NPV, probability that a negative test is a true negative) of NIRS for predicting ICH as detected on head CT was calculated using SPSS version 15.0 (SPSS Inc,. Chicago, IL). All data are presented as mean -standard error of the mean (SEM) unless otherwise specified.
Results
Patient enrollment and demographics
Demographics and diagnoses of the subjects are summarized in Table 1 . A total of 29 subjects were originally enrolled in the study; 1 child was excluded when the parents refused NIRS testing, leaving a study population of 28 children. Within this population, 15 children received CT scans for nontraumatic medical conditions, and 13 underwent head CT scans for concerns about traumatic intracranial injury.
The mean age was 2.6 -0.86 years, with a range of 1 day to 14 years. The CT scan was abnormal in 21 children (75%) and normal in 7 children (25%). Twelve of the 21 children with an abnormal head CT scan had an ICH, while 16 did not ( Table 2 ). Of the 12 children with ICH, 4 for had isolated acute SDH, 3 had acute and chronic SDH, 1 had an EDH, and 1 had an SAH (Table 3 ). An additional 9 subjects had abnormal CT findings without ICH (agenesis of the corpus callosum, bilateral chronic fluid collections, posterior fossa cyst, cerebral edema, bilateral frontal contusions, empyema, fracture, cerebral infarction, and subgaleal hematoma; Table 4 ).
Near-infrared spectroscopy measurements and relationship to intracranial hemorrhage
The time needed to complete all NIRS measurements in the accessible scalp locations was no more than 15 min for any subject. All eight NIRS regions were successfully assessed in 22 of 28 (79%) subjects. In the remaining subjects, the occipital (n = 6), and/or parietal (n = 2) regions were unable to be assessed due to the presence of cervical collars or wound dressings. A plurality of subjects (11/28, 39%) were mechanically ventilated and sedated at the time of NIRS testing. Of those children not requiring mechanical ventilation, infants were assessed either at the bedside with the child asleep in bed or while a caregiver/nurse held the child. Older children ( > 4 years) were able to tolerate the performance of measurements after simple explanation and instruction and did not require any additional interventions.
Of the 12 children with ICH, all subjects demonstrated at least 1 abnormal NIRS measurement at the time of testing (1.7 sites -0.8 site; Table 3 ). Figure 2 illustrates an example of one of these children. In the 9 children with an abnormal CT scan but without ICH, 2 had at least 1 abnormal NIRS measurement at the time of testing; these were considered FIG. 1. Scalp locations for near infrared spectroscope placement (F, frontal; P, parietal; T, temporal; O, occipital).
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false-positives. In each case the abnormal NIRS measurement was at the site of the abnormality: a subgaleal hematoma in one case and a cerebral infarction in the other. In the 7 children with a normal CT scan, 6 (86%) had normal NIRS measurements at all sites; 1 had abnormal NIRS measurements, and this was most likely due to technical difficulty in performing the measurements due to patient movement, or other confounding effects resulting in a false-positive result.
The sensitivity, specificity, and positive and negative predictive values of the NIRS device relative to ICH detection were calculated. The sensitivity and specificity of NIRS were 1.0 and 0.8, respectively. The positive and negative predictive values were 0.8 and 1.0, respectively.
Discussion
This is the first study to evaluate the use of NIRS to detect ICH in children. The results of this exploratory study suggest that this technique is feasible and has potential utility as a screening tool in a clinical setting to detect ICH without imposing any additional risks to the patient.
Clinical studies have recognized the importance of early identification of causes of brain injury (i.e., delayed hematomas, hypoxia, and ischemia) in an effort to prevent secondary brain injury and improve neurological outcome. Moreover, successfully detecting occult ICH in victims of child abuse with a device that constitutes no risk to the subject is an extremely attractive addition to the armamentarium of the bedside clinician, not to be used as a diagnostic tool, but rather as a device that might detect brain injury as a cause of presenting symptoms. With such a device, children with nonspecific symptoms or signs and a normal GCS could subsequently be screened in the ED setting for any suggestion of ICH. Then appropriate secondary testing with CT scans or other imaging modalities could confirm the initial findings.
NIRS technology offers many benefits to the bedside clinician. It is a portable painless bedside tool that can be gently applied to the scalp to quickly perform measurements. The device itself can perform readings on all eight scalp locations in 3-5 min under ideal circumstances. A more realistic time requirement when performing measurements on infants and children is 8-10 min, accounting for the varying levels of cooperation of children due to their short attention span, associated movements, and the need to repeat measurements. Another attractive feature of the NIRS device is its applicability to two different clinical settings: the ED with a clinically stable patient or in the PICU with a critically ill patient. Measurements on subjects in our study were frequently performed on sleeping infants and children while lying in their parents' arms or in a crib/bed with minimal disruption to their sleep. Measurements were also carefully and successfully obtained by a trained operator on critically ill subjects in the PICU who were mechanically ventilated and sedated, with different obstacles to overcome with regard to NIRS placement, such as electroencephalogram (EEG) leads present on the scalp, and intracranial monitoring devices present, including external ventricular drains, used to both measure ICP and drain CSF when needed. Another potential benefit of utilizing NIRS in the PICU population might be the early detection of a new bleed, although that was not the aim of this study.
Although this study provides promising initial data regarding the use of NIRS in children, there are several limitations to the study and to the NIRS device itself. First, the presence of bilateral ICH would limit the utility of NIRS, since the technique relies on comparison of light absorption between the hemispheres. In AHT, interhemispheric SDH occurs more commonly (Ewing-Cobbs et al., 2000) , and that might limit its application in this patient population. The purpose of utilizing NIRS technology is not to use it in isolation for the detection of occult head injuries, but rather to incorporate it into a battery of tools used in the detection of brain injury, including biomarkers, clinical decision rules, and other imaging modalities. Second, the depth of the ICH may be a limiting factor. Gopinath and colleagues (1993) demonstrated that intracranial hematomas absorb light less intensely than extracranial hematomas. Our data set is too small to know if this represents an important limitation. Third, the utility of NIRS in detecting subacute or chronic ICH could not be tested given our limited sample size and narrow time window to perform NIRS measurements (24 h ). NIRS may be less effective when hemoglobin is undergoing degradation in the subacute or chronic setting, a strong possibility in the context of AHT. One subject in our study was diagnosed with bilateral chronic subdural collections on head CT. These were subsequently identified as chronic subdural hemorrhages on MRI. NIRS was negative in this case; this suggests that NIRS may have one of the same limitations as head CT: the inability to identify chronic hemorrhage. Fourth, scalp hematomas can result in false-positive NIRS measurements, as occurred in our single subject with a subgaleal hematoma. NIRS data must be interpreted with caution in patients with more superficial injuries (i.e., scalp hematomas), and must be validated with the gold standard, head CT, for the detection of ICH. Fifth, approximately 20% of our patient population had scalp locations that could not be examined with the NIRS device due to the presence of cervical collars limiting manipulation of the head, which is needed to obtain the measurements. In no case, however, did this result in a false-negative result. We had technical difficulty in performing NIRS on one subject, and this may have been related to patient movement or other possible confounding effects resulting in a false-positive result. This limitation may be more important in the ED setting with children who are less critically ill and therefore more likely to be moving. Lastly, NIRS technology is designed for the detection of acute ICH in eight scalp locations based on DOD values. It does not provide any further information that would direct medical versus surgical management of ICH (i.e., presence or absence of midline shift, impending herniation, or size of the ICH). Normal NIRS measurements would also not eliminate the possibility of severe brain injury without ICH (i.e., DAI). Our study was limited by the small sample size, by the fact that all NIRS measurements were performed by a single operator in a single institution, and by the fact that the NIRS operator was not completely blinded to CT results. Performing NIRS measurements prior to head CT would eliminate any bias in obtaining NIRS measurements.
We conclude that NIRS measurements predicted the presence of ICH in the majority of patients with CT images identifying ICH. These exploratory results suggest that NIRS may be a beneficial adjunct in the rapid evaluation of an infant or child with suspected TBI in an emergent setting when CT imaging may not be imminently available, or as a screening tool to guide further clinical management. Normal NIRS measurements, however, cannot rule out the possibility of TBI from AHT or other causes, since diffuse brain injury and other forms of TBI without a contusion or hemorrhage are well described. The importance of developing alternate methods to head CT to rapidly assess infants and children with suspected intracranial pathology in the clinical setting and to guide clinical decision-making is of utmost importance, and needs to be a focus of further pediatric research.
